Browsing by Author Anjomani-Virmouni, S
Showing results 1 to 15 of 15
Issue Date | Title | Author(s) |
---|---|---|
2016 | Analysis of alternative lengthening of telomere markers in BRCA1 defective cells | Kargaran, PK; Yasaei, H; Anjomani-Virmouni, S; Mangiapane, G; Slijepcevic, P |
14-Nov-2019 | Elucidation of the metabolic signature of Friedreich’s ataxia | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Perry, N; Tripp, A; Agliano, A; Al-Mahdawi, S; Pook, M |
6-Feb-2024 | Emerging antioxidant therapies in Friedreich's ataxia | Edzeamey, FJ; Ramchunder, Z; Pourzand, C; Anjomani-Virmouni, S |
2024 | Galleria mellonella as a drug discovery model for oxidative stress in Friedreich’s ataxia (FRDA). | Edzeamey, FJ; Ramchunder, Z; McCarthy, R; Anjomani-Virmouni, S |
2014 | Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models | Sandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA |
14-Nov-2019 | Genotype and Phenotype Characterisation of an Enhanced Friedreich Ataxia GAA Repeat Expansion Mouse Model Fxn_null::YG8s(GAA)>800 | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Kleine, P; Oggianu, C; Hannana, T; Al-Mahdawi, S; Pook, M |
2015 | Genotype and phenotype characterisation of enhanced Friedreich’s ataxia GAA repeat expansion mouse models | Anjomani Virmouni, S; Sandi, C; Ezzatizadeh, V; Sandi, M; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
5-Jun-2020 | HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s Ataxia | Sherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
2014 | MutLα heterodimers modify the molecular phenotype of Friedreich ataxia | Ezzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA |
2019 | Near Real-time Stratification of PIK3CA Mutant Breast Cancers Using the iKnife | Koundouros, N; Tripp, A; Karali, E; Valle, A; Inglese, P; Anjomani-Virmouni, S; Elder, G; van Weverwijk, A; Filipe-Soares, R; Isacke, C; Nicholson, J; Glen, RC; Takats, Z; Poulogiannis, G |
16-Mar-2017 | PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation | Gupta, A; Anjomani-Virmouni, S; Koundouros, N; Dimitriadi, M; Choo-Wing, R; Valle, A; Zheng, Y; Chiu, YH; Agnihotri, S; Zadeh, G; Asara, JM; Anastasiou, D; Arends, MJ; Cantley, LC; Poulogiannis, G |
19-May-2017 | PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN | Gupta, A; Anjomani-Virmouni, S; Koundouros, N; Poulogiannis, G |
1-Nov-2016 | Proteomics profiling of interactome dynamics by colocalisation analysis (COLA) | Mardakheh, FK; Sailem, HZ; Kümper, S; Tape, CJ; McCully, RR; Paul, A; Anjomani-Virmouni, S; Jørgensen, C; Poulogiannis, G; Marshall, CJ; Bakal, C |